Lecithin based lamellar liquid crystals as a physiologically acceptable dermal delivery system for ascorbyl palmitate

被引:71
作者
Gosenca, Mirjam [1 ]
Bester-Rogac, Marija [2 ]
Gasperlin, Mirjana [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Ljubljana 71000, Slovenia
[2] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 71000, Slovenia
关键词
Pseudoternary phase diagram; Lamellar liquid crystalline phase; Ascorbyl palmitate; Keratinocytes; Cytotoxicity; PHASE-BEHAVIOR; RHEOLOGICAL PROPERTIES; WATER BEHAVIOR; CUBIC PHASE; MICROEMULSIONS; SKIN; SURFACTANT; FORMULATION; MIXTURES; DIAGRAMS;
D O I
10.1016/j.ejps.2013.04.029
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liquid crystalline systems with a lamellar structure have been extensively studied as dermal delivery systems. Ascorbyl palmitate (AP) is one of the most studied and used ascorbic acid derivatives and is employed as an antioxidant to prevent skin aging. The aim of this study was to develop and characterize skin-compliant dermal delivery systems with a liquid crystalline structure for AP. First, a pseudoternary phase diagram was constructed using Tween 80/lecithin/isopropyl myristate/water at a Tween 80/lecithin mass ratio of 1/1, and the region of lamellar liquid crystals was identified. Second, selected unloaded and AP-loaded lamellar liquid crystal systems were physicochemically characterized with polarizing optical microscopy, small-angle X-ray scattering, differential scanning calorimetry, and rheology techniques. The interlayer spacing and rheological parameters differ regarding quantitative composition, whereas the microstructure of the lamellar phase was affected by the AP incorporation, resulting either in additional micellar structures (at 25 and 32 degrees C) or being completely destroyed at higher temperature (37 degrees C). After this, the study was oriented towards in vitro cytotoxicity evaluation of lamellar liquid crystal systems on a keratinocyte cell line. The results suggest that the lamellar liquid crystals that were developed could be used as a physiologically acceptable dermal delivery system. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 54 条
  • [1] Phase Behavior, Formation, and Rheology of Cubic Phase and Related Gel Emulsion in Tween80/Water/Oil Systems
    Alam, Mohammad Mydul
    Ushiyama, Kousuke
    Aramaki, Kenji
    [J]. JOURNAL OF OLEO SCIENCE, 2009, 58 (07) : 361 - 367
  • [2] Molecular dynamics simulation of a polysorbate 80 micelle in water
    Amani, Amir
    York, Peter
    de Waard, Hans
    Anwar, Jamshed
    [J]. SOFT MATTER, 2011, 7 (06) : 2900 - 2908
  • [3] The ascorbyl palmitate-polyethyleneglycol 400-water system phase behavior
    Benedini, Luciano
    Messina, Paula V.
    Palma, Santiago D.
    Allemandi, Daniel A.
    Schulz, Pablo C.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2012, 89 : 265 - 270
  • [4] The ascorbyl palmitate-water system: Phase diagram and state of water
    Benedini, Luciano
    Schulz, Erica P.
    Messina, Paula V.
    Palma, Santiago D.
    Allemandi, Daniel A.
    Schulz, Pablo C.
    [J]. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2011, 375 (1-3) : 178 - 185
  • [5] A review of the rheology of the lamellar phase in surfactant systems
    Berni, MG
    Lawrence, CJ
    Machin, D
    [J]. ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2002, 98 (02) : 217 - 243
  • [6] Bonacucina G., 2012, DRUG DEV IND PHARM, P1
  • [7] Burducea G., 2004, ROM REP PHYS, V56, P66
  • [8] Effect of short-chain alcohols as co-surfactants on pseudo-ternary phase diagrams containing lecithin
    Choi, SY
    Oh, SG
    Bae, SY
    Moon, SK
    [J]. KOREAN JOURNAL OF CHEMICAL ENGINEERING, 1999, 16 (03) : 377 - 381
  • [9] Structural characterization and in vivo evaluation of retinyl palmitate in non-ionic lamellar liquid crystalline system
    Chorilli, M.
    Prestes, P. S.
    Rigon, R. B.
    Leonardi, G. R.
    Chiavacci, L. A.
    Sarmento, V. H. V.
    Oliveira, A. G.
    Scarpa, M. V.
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 85 (02) : 182 - 188
  • [10] Dreher F, 1996, SKIN PHARMACOL, V9, P124